TEAM HEALTH HOLDINGS INC. 4
4 · TEAM HEALTH HOLDINGS INC. · Filed Nov 19, 2014
Insider Transaction Report
Form 4
ROTH GREG
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Common Stock
2014-11-17$21.64/sh+14,865$321,679→ 147,729 total - Sale
Common Stock
2014-11-17$54.41/sh−4,135$224,982→ 132,864 total - Exercise/Conversion
Stock Options (Right to Buy)
2014-11-17−4,135→ 140,865 totalExercise: $22.09Exp: 2022-05-18→ Common Stock (4,135 underlying) - Sale
Common Stock
2014-11-17$54.41/sh−14,865$808,793→ 132,864 total - Exercise/Conversion
Common Stock
2014-11-17$22.09/sh+4,135$91,342→ 136,999 total - Exercise/Conversion
Stock Options (Right to Buy)
2014-11-17−14,865→ 36,250 totalExercise: $21.64Exp: 2021-05-26→ Common Stock (14,865 underlying) - Sale
Common Stock
2014-11-17$54.39/sh−4,600$250,187→ 132,864 total
Footnotes (8)
- [F1]These shares were sold pursuant to a Rule 10b5-1 Sales Plan dated May 8, 2014 between the Shareholder and Morgan Stanley Smith Barney, LLC.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.15 to $54.70, inclusive. The reporting person undertakes to provide to Team Health Holdings, Inc., any security holder of Team Health Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]These shares were acquired and subsequently sold pursuant to a Rule 10b5-1 Sales Plan dated May 8, 2014 between the Shareholder and Morgan Stanley Smith Barney, LLC.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.15 to $54.72, inclusive. The reporting person undertakes to provide to Team Health Holdings, Inc., any security holder of Team Health Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]These shares were acquired and subsequently sold pursuant to stock options exercised under a Rule 10b5-1 Sales Plan dated May 8, 2014 between the Shareholder and Morgan Stanley Smith Barney, LLC.
- [F6]These stock options were exercised and the underlying shares sold pursuant to a Rule 10b5-1 Sales Plan dated May 8, 2014 between the Shareholder and Morgan Stanley Smith Barney, LLC.
- [F7]The stock options are vested and exercisable with respect to 75% of the underlying shares and shall vest and become exercisable with respect to the remaining 25% of the shares on the fourth anniversary of the May 26, 2011 grant date.
- [F8]These stock options are vested and exercisable with respect to 25% of the underlying shares and shall vest and become exercisable with respect to the remaining shares in 25% increments on each of the second, third and fourth anniversaries of the May 18, 2012 grant date.